Regulatory Brief

 Transatlantic Task Force on Antimicrobial Resistance


Formal title: Stakeholder Consultation on the Transatlantic Task Force on Antimicrobial Resistance; Combating Antibiotic Resistance in Transatlantic Cooperation


Brief Description:

The public consultation provides an opportunity for the public to provide their views on the EU/US Transatlantic Taskforce on Antimicrobial Resistance to the Commission (TATFAR). The objective is to use this feedback for drafting the TATFAR report to the European Union (EU)-United States (US) Summit of 2011 and to potentially provide input on other policy initiatives in relation to antimicrobial resistance.

AVMA Response:

The AVMA commends the Task Force for accepting the definition of therapeutic use of antimicrobials in veterinary medicine to be consistent with the AVMA, the U.S. Food and Drug Administration, and the Codex Alimentarius Commission on the inclusion of treatment, control, and prevention of disease as therapeutic.

As the only profession that routinely operates at the interface between human and animal health, the AVMA encouraged the Task Force to continue to promote cooperation between human and animal health professionals. The AVMA was a key stakeholder in the development of the United States' Public Health Action Plan to Combat Antimicrobial Resistance, helping to ensure that the plan provided a blueprint detailing coordinated federal actions that are critically needed if we are to mitigate the threat of antimicrobial resistance. Many of the actions recommended in the plan are specific antimicrobial resistance-related activities where intensified cooperation between the United States and the European Union could have great impact. Ensuring appropriate therapeutic uses of antimicrobials can be closely linked to surveillance and monitoring of antimicrobial use.

The AVMA is strongly supportive of extending the TATFAR mandate to seek necessary funding to appropriately address the issues within its focus areas. The AVMA remains optimistic that the Task Force will continue to follow the mandate outlined and succeed in enhancing cooperation among the human and veterinary medical professions, the US, and the EU.

Background Documents:

http://ec.europa.eu/health/antimicrobial_resistance/consultations/antimicrobial_cons_01_en.htm

The AVMA responded on December 17, 2010. (PDF)